Abstract # 2094 Acute Toxicity in a Phase II Clinical Trial of Valproic Acid in Combination with Temodar and Radiation Therapy in Patients with Glioblastoma Multiforme

Presenter: Kamrava, Mitchell

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
I am a PGY4 resident in Radiation Oncology at the National Cancer Institute.

M. Kamrava1, D. Citrin1, M. Sproull1, E. Lita1, S. Smith1, N. Sears-Crouse1, T. Cooley-Zgela1, H. Fine2, K. Camphausen1, 1Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, 2Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD

Author Disclosure:
 M. Kamrava, None; D. Citrin, None; M. Sproull, None; E. Lita, None; S. Smith, None; N. Sears-Crouse, None; T. Cooley-Zgela, None; H. Fine, None; K. Camphausen, None.

E-mail a friend about this abstract:
Enter email address: